These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 25542680
1. TPGS-chitosome as an effective oral delivery system for improving the bioavailability of Coenzyme Q10. Shao Y, Yang L, Han HK. Eur J Pharm Biopharm; 2015 Jan; 89():339-46. PubMed ID: 25542680 [Abstract] [Full Text] [Related]
2. Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy. Rossi I, Sonvico F, McConville JT, Rossi F, Fröhlich E, Zellnitz S, Rossi A, Del Favero E, Bettini R, Buttini F. Eur J Pharm Sci; 2018 Feb 15; 113():159-170. PubMed ID: 29066385 [Abstract] [Full Text] [Related]
3. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome. Qiang F, Shin HJ, Lee BJ, Han HK. Int J Pharm; 2012 Jul 01; 430(1-2):161-6. PubMed ID: 22525082 [Abstract] [Full Text] [Related]
4. Improved oral bioavailability of alendronate via the mucoadhesive liposomal delivery system. Han HK, Shin HJ, Ha DH. Eur J Pharm Sci; 2012 Aug 15; 46(5):500-7. PubMed ID: 22522117 [Abstract] [Full Text] [Related]
5. Preparation and Characterization of Mucoadhesive Nanoparticles for Enhancing Cellular Uptake of Coenzyme Q10. Lee JS, Suh JW, Kim ES, Lee HG. J Agric Food Chem; 2017 Oct 11; 65(40):8930-8937. PubMed ID: 28933847 [Abstract] [Full Text] [Related]
6. Preparation and characterization of liposomal coenzyme Q10 for in vivo topical application. Lee WC, Tsai TH. Int J Pharm; 2010 Aug 16; 395(1-2):78-83. PubMed ID: 20635514 [Abstract] [Full Text] [Related]
7. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Feng SS, Mei L, Anitha P, Gan CW, Zhou W. Biomaterials; 2009 Jul 16; 30(19):3297-306. PubMed ID: 19299012 [Abstract] [Full Text] [Related]
8. Preparation and Characterization of Syringic Acid-Loaded TPGS Liposome with Enhanced Oral Bioavailability and In Vivo Antioxidant Efficiency. Liu Y, Sun C, Li W, Adu-Frimpong M, Wang Q, Yu J, Xu X. AAPS PharmSciTech; 2019 Feb 04; 20(3):98. PubMed ID: 30719694 [Abstract] [Full Text] [Related]
9. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN. Eur J Pharm Biopharm; 2007 Sep 04; 67(2):361-9. PubMed ID: 17452099 [Abstract] [Full Text] [Related]
10. Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies. Zhao L, Feng SS. J Pharm Sci; 2010 Aug 04; 99(8):3552-60. PubMed ID: 20564384 [Abstract] [Full Text] [Related]
11. Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel. Raju A, Muthu MS, Feng SS. Expert Opin Drug Deliv; 2013 Jun 04; 10(6):747-60. PubMed ID: 23458409 [Abstract] [Full Text] [Related]
12. PEGylated Solanesol for Oral Delivery of Coenzyme Q10. Qin B, Liu L, Pan Y, Zhu Y, Wu X, Song S, Han G. J Agric Food Chem; 2017 Apr 26; 65(16):3360-3367. PubMed ID: 28418660 [Abstract] [Full Text] [Related]
13. Chitosan-coated liposome-containing carbamazepine and coenzyme Q10: design, optimization and evaluation. Sağıroğlu AA. J Liposome Res; 2021 Dec 26; 31(4):389-398. PubMed ID: 33183104 [Abstract] [Full Text] [Related]
14. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan. Lee JY, Kang WS, Piao J, Yoon IS, Kim DD, Cho HJ. Drug Des Devel Ther; 2015 Dec 26; 9():2745-56. PubMed ID: 26045660 [Abstract] [Full Text] [Related]
15. Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems. Balakrishnan P, Lee BJ, Oh DH, Kim JO, Lee YI, Kim DD, Jee JP, Lee YB, Woo JS, Yong CS, Choi HG. Int J Pharm; 2009 Jun 05; 374(1-2):66-72. PubMed ID: 19446761 [Abstract] [Full Text] [Related]
16. Lyotropic liquid crystalline nanoparticles of CoQ10: implication of lipase digestibility on oral bioavailability, in vivo antioxidant activity, and in vitro-in vivo relationships. Swarnakar NK, Thanki K, Jain S. Mol Pharm; 2014 May 05; 11(5):1435-49. PubMed ID: 24742138 [Abstract] [Full Text] [Related]
17. Plasma coenzyme Q10 response to oral ingestion of coenzyme Q10 formulations. Bhagavan HN, Chopra RK. Mitochondrion; 2007 Jun 05; 7 Suppl():S78-88. PubMed ID: 17482886 [Abstract] [Full Text] [Related]
18. Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies. Kala SG, Chinni S. Drug Deliv Transl Res; 2022 Nov 05; 12(11):2856-2864. PubMed ID: 35322372 [Abstract] [Full Text] [Related]
19. Preparation, in vitro Characterization and Pharmacokinetic Study of Coenzyme Q10 Long-Circulating Liposomes. Yang S. Drug Res (Stuttg); 2018 May 05; 68(5):270-279. PubMed ID: 29190857 [Abstract] [Full Text] [Related]
20. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome. Zhao M, Lee SH, Song JG, Kim HY, Han HK. Int J Pharm; 2018 Jun 10; 544(1):14-20. PubMed ID: 29655795 [Abstract] [Full Text] [Related] Page: [Next] [New Search]